Verrica Pharmaceuticals Inc. - Common Stock (VRCA)

Verrica (VRCA) Q1 2026 Earnings Transcript

Verrica Pharmaceuticals (NASDAQ:VRCA) reported higher first-quarter revenue and record demand for its molluscum contagiosum treatment YCANTH, while outlining progress on late-stage development programs in common warts and basal cell carcinoma. President and Chief Executive Officer Jayson Rieger sai

Let's have a look at the gap up and gap down stocks in today's session.

Intrigued by the market activity one hour before the close of the markets on Friday? Uncover the key winners and losers of today's session in our insightful analysis.

Here are the top movers in Friday's session, showcasing the stocks with significant price changes.

Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.